181 related articles for article (PubMed ID: 34379946)
1. A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance.
Chatterjee M; Neema S; Rajput GR
Indian J Dermatol Venereol Leprol; 2021; 88(1):51-58. PubMed ID: 34379946
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
Guevara IL; Pandya AG
Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
[TBL] [Abstract][Full Text] [Related]
3. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
4. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
Pratchyapurit WO
J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
[TBL] [Abstract][Full Text] [Related]
5. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma.
Sarkar R; Ghunawat S; Narang I; Verma S; Garg VK; Dua R
J Cosmet Dermatol; 2019 Aug; 18(4):1066-1073. PubMed ID: 31033184
[TBL] [Abstract][Full Text] [Related]
6. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
[TBL] [Abstract][Full Text] [Related]
8. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
9. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial.
Lima PB; Dias JAF; Esposito ACC; Miot LDB; Miot HA
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):502-508. PubMed ID: 32841433
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
Nanda S; Grover C; Reddy BS
Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
[TBL] [Abstract][Full Text] [Related]
12. Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
Arellano I; Cestari T; Ocampo-Candiani J; Azulay-Abulafia L; Bezerra Trindade Neto P; Hexsel D; Machado-Pinto J; Muñoz H; Rivitti-Machado MC; Sittart JA; Trindade de Almeida AR; Rego V; Paliargues F; Marques-Hassun K
J Eur Acad Dermatol Venereol; 2012 May; 26(5):611-8. PubMed ID: 21623930
[TBL] [Abstract][Full Text] [Related]
13. An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation.
Cantelli M; Ferrillo M; Granger C; Fabbrocini G
J Cosmet Dermatol; 2022 Apr; 21(4):1523-1532. PubMed ID: 34087055
[TBL] [Abstract][Full Text] [Related]
14. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.
Ramírez SP; Carvajal AC; Salazar JC; Arroyave G; Flórez AM; Echeverry HF
J Drugs Dermatol; 2013 Jun; 12(6):e106-10. PubMed ID: 23839199
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
[TBL] [Abstract][Full Text] [Related]
16. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
17. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
[TBL] [Abstract][Full Text] [Related]
18. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.
Farshi S
J Cosmet Dermatol; 2011 Dec; 10(4):282-7. PubMed ID: 22151936
[TBL] [Abstract][Full Text] [Related]
20. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma.
Haddad AL; Matos LF; Brunstein F; Ferreira LM; Silva A; Costa D
Int J Dermatol; 2003 Feb; 42(2):153-6. PubMed ID: 12709008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
